Skip to main content
Erschienen in: European Radiology 5/2021

12.11.2020 | Gastrointestinal

Multiparametric MRI-based radiomics signature for preoperative estimation of tumor-stroma ratio in rectal cancer

verfasst von: Chongpeng Cai, Tingdan Hu, Jing Gong, Dan Huang, Fangqi Liu, Caixia Fu, Tong Tong

Erschienen in: European Radiology | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

To determine whether a radiomics signature (rad-score) outperforms ADC in TSR estimation by developing a radiomics biomarker for preoperative TSR diagnosis in rectal cancer.

Methods

This study included 149 patients (119 and 30 in the training and validation cohorts, respectively). All patients underwent T2-weighted, diffusion-weighted, and contrast-enhanced T1-weighted imaging. A rad-score was generated using the least absolute shrinkage and selection operator (LASSO) algorithm and stepwise multivariate logistic regression. Meanwhile, the mean ADCs were calculated from ADC maps. For both the mean ADC and rad-score, binary logistic regression and Spearman correlation coefficients were used to determine associations with the TSR, and the area under the receiver operating characteristic (ROC) curve was used to assess the diagnostic performance. The reliability of the rad-score was quantified by comparing the imaging-estimated TSR with the actual TSR of each patient.

Results

Both the mean ADC and rad-score were positively correlated with the TSR in the training cohort (mean ADC: p < 0.001, r = 0.566; rad-score: p < 0.001, r = 0.559) and validation cohort (mean ADC: p < 0.001, r = 0.671; rad-score: p = 0.002, r = 0.536). The rad-score, with AUCs of 0.917 (95% CI 0.869–0.965) and 0.787 (95% CI 0.602–0.972) in the training and validation cohorts, respectively, outperformed the mean ADC (training cohort: AUC = 0.776, 95% CI 0.693–0.859; validation cohort: AUC = 0.764, 95% CI 0.592–0.936) in TSR estimation.

Conclusion

The ADC possesses potential diagnostic value for TSR estimation in rectal cancer, and the rad-score shows increased diagnostic value over the ADC and may be a promising supplemental tool for patient stratification and informing decision-making.

Key Points

• Tumor-stroma ratio has been verified as an independent prognostic factor for various solid tumors including rectal cancer.
• The ADC and multiparametric MRI-based radiomics features were significantly and positively correlated with the tumor-stroma ratio in rectal cancer.
• The radiomics signature outperformed the ADC in discriminating TSR in rectal cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34PubMed Siegel RL, Miller KD, Jemal A (2019) Cancer statistics, 2019. CA Cancer J Clin 69:7–34PubMed
2.
Zurück zum Zitat Miller KD, Nogueira L, Mariotto AB et al (2019) Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 69:363–385CrossRefPubMed Miller KD, Nogueira L, Mariotto AB et al (2019) Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin 69:363–385CrossRefPubMed
3.
Zurück zum Zitat Giraldo NA, Sanchez-Salas R, Peske JD et al (2019) The clinical role of the TME in solid cancer. Br J Cancer 120:45–53CrossRefPubMed Giraldo NA, Sanchez-Salas R, Peske JD et al (2019) The clinical role of the TME in solid cancer. Br J Cancer 120:45–53CrossRefPubMed
4.
Zurück zum Zitat Li X, Wang P, Li D et al (2018) Intravoxel incoherent motion MR imaging of early cervical carcinoma: correlation between imaging parameters and tumor-stroma ratio. Eur Radiol 28:1875–1883CrossRefPubMed Li X, Wang P, Li D et al (2018) Intravoxel incoherent motion MR imaging of early cervical carcinoma: correlation between imaging parameters and tumor-stroma ratio. Eur Radiol 28:1875–1883CrossRefPubMed
5.
Zurück zum Zitat Downey CL, Simpkins SA, White J et al (2014) The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer. Br J Cancer 110:1744–1747CrossRefPubMedPubMedCentral Downey CL, Simpkins SA, White J et al (2014) The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer. Br J Cancer 110:1744–1747CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Peng C, Liu J, Yang G, Li Y (2018) The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system. J Gastroenterol 53:606–617CrossRefPubMed Peng C, Liu J, Yang G, Li Y (2018) The tumor-stromal ratio as a strong prognosticator for advanced gastric cancer patients: proposal of a new TSNM staging system. J Gastroenterol 53:606–617CrossRefPubMed
7.
Zurück zum Zitat Labiche A, Heutte N, Herlin P, Chasle J, Gauduchon P, Elie N (2010) Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma. Int J Gynecol Cancer 20:28–33CrossRefPubMed Labiche A, Heutte N, Herlin P, Chasle J, Gauduchon P, Elie N (2010) Stromal compartment as a survival prognostic factor in advanced ovarian carcinoma. Int J Gynecol Cancer 20:28–33CrossRefPubMed
8.
Zurück zum Zitat West NP, Dattani M, McShane P et al (2010) The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. Br J Cancer 102:1519–1523CrossRefPubMedPubMedCentral West NP, Dattani M, McShane P et al (2010) The proportion of tumour cells is an independent predictor for survival in colorectal cancer patients. Br J Cancer 102:1519–1523CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Huijbers A, Tollenaar RA, Pelt GW et al (2013) The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol 24:179–185CrossRefPubMed Huijbers A, Tollenaar RA, Pelt GW et al (2013) The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol 24:179–185CrossRefPubMed
10.
Zurück zum Zitat Moorman AM, Vink R, Heijmans HJ, van der Palen J, Kouwenhoven EA (2012) The prognostic value of tumour-stroma ratio in triple-negative breast cancer. Eur J Surg Oncol 38:307–313CrossRefPubMed Moorman AM, Vink R, Heijmans HJ, van der Palen J, Kouwenhoven EA (2012) The prognostic value of tumour-stroma ratio in triple-negative breast cancer. Eur J Surg Oncol 38:307–313CrossRefPubMed
11.
Zurück zum Zitat Geessink O, Baidoshvili A, Klaase JM et al (2019) Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer. Cell Oncol (Dordr) 42:331–341CrossRef Geessink O, Baidoshvili A, Klaase JM et al (2019) Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer. Cell Oncol (Dordr) 42:331–341CrossRef
12.
Zurück zum Zitat Mesker WE, Junggeburt JM, Szuhai K et al (2007) The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol 29:387–398PubMedPubMedCentral Mesker WE, Junggeburt JM, Szuhai K et al (2007) The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol 29:387–398PubMedPubMedCentral
13.
Zurück zum Zitat Driessen JP, Caldas-Magalhaes J, Janssen LM et al (2014) Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings. Radiology 272:456–463CrossRefPubMed Driessen JP, Caldas-Magalhaes J, Janssen LM et al (2014) Diffusion-weighted MR imaging in laryngeal and hypopharyngeal carcinoma: association between apparent diffusion coefficient and histologic findings. Radiology 272:456–463CrossRefPubMed
14.
Zurück zum Zitat Ko ES, Han BK, Kim RB et al (2014) Apparent diffusion coefficient in estrogen receptor-positive invasive ductal breast carcinoma: correlations with tumor-stroma ratio. Radiology 271:30–37CrossRefPubMed Ko ES, Han BK, Kim RB et al (2014) Apparent diffusion coefficient in estrogen receptor-positive invasive ductal breast carcinoma: correlations with tumor-stroma ratio. Radiology 271:30–37CrossRefPubMed
15.
Zurück zum Zitat Scheer R, Baidoshvili A, Zoidze S et al (2017) Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: a retrospective cohort study. World J Gastrointest Oncol 9:466–474CrossRefPubMedPubMedCentral Scheer R, Baidoshvili A, Zoidze S et al (2017) Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: a retrospective cohort study. World J Gastrointest Oncol 9:466–474CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Almangush A, Heikkinen I, Bakhti N et al (2018) Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers. Histopathology 72:1128–1135CrossRefPubMed Almangush A, Heikkinen I, Bakhti N et al (2018) Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers. Histopathology 72:1128–1135CrossRefPubMed
17.
Zurück zum Zitat Liu H, Zhang C, Wang L et al (2019) MRI radiomics analysis for predicting preoperative synchronous distant metastasis in patients with rectal cancer. Eur Radiol 29:4418–4426CrossRefPubMed Liu H, Zhang C, Wang L et al (2019) MRI radiomics analysis for predicting preoperative synchronous distant metastasis in patients with rectal cancer. Eur Radiol 29:4418–4426CrossRefPubMed
18.
Zurück zum Zitat Cui Y, Yang X, Shi Z et al (2019) Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 29:1211–1220CrossRefPubMed Cui Y, Yang X, Shi Z et al (2019) Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol 29:1211–1220CrossRefPubMed
19.
Zurück zum Zitat Schurink NW, Min LA, Berbee M et al (2020) Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation. Eur Radiol 30:2945–2954CrossRefPubMed Schurink NW, Min LA, Berbee M et al (2020) Value of combined multiparametric MRI and FDG-PET/CT to identify well-responding rectal cancer patients before the start of neoadjuvant chemoradiation. Eur Radiol 30:2945–2954CrossRefPubMed
20.
Zurück zum Zitat Cui Y, Liu H, Ren J et al (2020) Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer. Eur Radiol 30:1948–1958CrossRefPubMed Cui Y, Liu H, Ren J et al (2020) Development and validation of a MRI-based radiomics signature for prediction of KRAS mutation in rectal cancer. Eur Radiol 30:1948–1958CrossRefPubMed
21.
Zurück zum Zitat Meng X, Xia W, Xie P et al (2019) Preoperative radiomic signature based on multiparametric magnetic resonance imaging for noninvasive evaluation of biological characteristics in rectal cancer. Eur Radiol 29:3200–3209CrossRefPubMed Meng X, Xia W, Xie P et al (2019) Preoperative radiomic signature based on multiparametric magnetic resonance imaging for noninvasive evaluation of biological characteristics in rectal cancer. Eur Radiol 29:3200–3209CrossRefPubMed
22.
Zurück zum Zitat Fu M, Chen D, Luo F et al (2020) Association of the tumour stroma percentage in the preoperative biopsies with lymph node metastasis in colorectal cancer. Br J Cancer 122:388–396CrossRefPubMed Fu M, Chen D, Luo F et al (2020) Association of the tumour stroma percentage in the preoperative biopsies with lymph node metastasis in colorectal cancer. Br J Cancer 122:388–396CrossRefPubMed
23.
Zurück zum Zitat Li XT, Sun YS, Tang L, Cao K, Zhang XY (2015) Evaluating local lymph node metastasis with magnetic resonance imaging, endoluminal ultrasound and computed tomography in rectal cancer: a meta-analysis. Colorectal Dis 17:O129–O135CrossRefPubMed Li XT, Sun YS, Tang L, Cao K, Zhang XY (2015) Evaluating local lymph node metastasis with magnetic resonance imaging, endoluminal ultrasound and computed tomography in rectal cancer: a meta-analysis. Colorectal Dis 17:O129–O135CrossRefPubMed
Metadaten
Titel
Multiparametric MRI-based radiomics signature for preoperative estimation of tumor-stroma ratio in rectal cancer
verfasst von
Chongpeng Cai
Tingdan Hu
Jing Gong
Dan Huang
Fangqi Liu
Caixia Fu
Tong Tong
Publikationsdatum
12.11.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 5/2021
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-020-07403-6

Weitere Artikel der Ausgabe 5/2021

European Radiology 5/2021 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.